Ketosurg-DS Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement used primarily in the management of chronic kidney disease (CKD). It serves as a precursor to essential amino acids, facilitating protein synthesis while minimizing nitrogenous waste production, thereby reducing the metabolic burden on compromised renal function. Ketosurg-DS is indicated for patients with CKD stages 3 to 5, particularly those on a low-protein diet, to help maintain nutritional status and delay the progression of uremic symptoms. The tablet aids in correcting protein-energy malnutrition by providing ketoanalogues of essential amino acids, which are transaminated in the body to form amino acids without increasing nitrogen load. This mechanism supports muscle mass preservation and overall metabolic balance. Ketosurg-DS should be administered under medical supervision, with dosage tailored according to the patient’s renal function, dietary protein intake, and clinical condition. It is not a substitute for dialysis or other renal replacement therapies but serves as an adjunct to dietary management. Caution is advised in patients with hepatic impairment or metabolic disorders. Common adverse effects are rare but may include gastrointestinal discomfort. Regular monitoring of renal parameters and nutritional status is recommended during therapy to optimize outcomes.